A detailed history of Sawgrass Asset Management LLC transactions in Amgen Inc stock. As of the latest transaction made, Sawgrass Asset Management LLC holds 25,093 shares of AMGN stock, worth $6.61 Million. This represents 0.85% of its overall portfolio holdings.

Number of Shares
25,093
Previous 36,943 32.08%
Holding current value
$6.61 Million
Previous $11.5 Million 29.95%
% of portfolio
0.85%
Previous 1.25%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$309.38 - $337.38 $3.67 Million - $4 Million
-11,850 Reduced 32.08%
25,093 $8.09 Million
Q2 2024

Jul 18, 2024

SELL
$262.75 - $319.31 $82,766 - $100,582
-315 Reduced 0.85%
36,943 $11.5 Million
Q1 2024

May 13, 2024

SELL
$268.87 - $324.56 $5.28 Million - $6.37 Million
-19,633 Reduced 34.51%
37,258 $10.6 Million
Q4 2023

Feb 06, 2024

SELL
$255.7 - $288.46 $872,704 - $984,513
-3,413 Reduced 5.66%
56,891 $16.4 Million
Q3 2023

Nov 13, 2023

SELL
$218.65 - $271.46 $614,843 - $763,345
-2,812 Reduced 4.46%
60,304 $16.2 Million
Q2 2023

Jul 13, 2023

SELL
$214.27 - $253.37 $900,576 - $1.06 Million
-4,203 Reduced 6.24%
63,116 $14 Million
Q1 2023

May 09, 2023

SELL
$225.79 - $275.2 $460,385 - $561,132
-2,039 Reduced 2.94%
67,319 $16.3 Million
Q4 2022

Feb 09, 2023

SELL
$229.03 - $291.01 $170,856 - $217,093
-746 Reduced 1.06%
69,358 $18.2 Million
Q3 2022

Nov 09, 2022

SELL
$224.46 - $253.15 $603,348 - $680,467
-2,688 Reduced 3.69%
70,104 $15.8 Million
Q2 2022

Aug 04, 2022

SELL
$230.71 - $256.74 $1.19 Million - $1.32 Million
-5,154 Reduced 6.61%
72,792 $17.7 Million
Q1 2022

May 18, 2022

BUY
$219.27 - $242.57 $17.1 Million - $18.9 Million
77,946 New
77,946 $18.8 Million
Q4 2021

Feb 03, 2022

SELL
$198.88 - $227.6 $17.6 Million - $20.2 Million
-88,659 Closed
0 $0
Q3 2021

Nov 04, 2021

SELL
$212.27 - $248.7 $3.14 Million - $3.68 Million
-14,782 Reduced 14.29%
88,659 $18.9 Million
Q2 2021

Aug 05, 2021

SELL
$233.58 - $259.14 $8.26 Million - $9.16 Million
-35,364 Reduced 25.48%
103,441 $25.2 Million
Q1 2021

Apr 29, 2021

SELL
$221.91 - $258.6 $4.93 Million - $5.75 Million
-22,235 Reduced 13.81%
138,805 $34.5 Million
Q4 2020

Jan 22, 2021

SELL
$216.38 - $257.67 $743,698 - $885,611
-3,437 Reduced 2.09%
161,040 $37 Million
Q3 2020

Nov 02, 2020

SELL
$234.65 - $260.95 $6.16 Million - $6.85 Million
-26,262 Reduced 13.77%
164,477 $41.8 Million
Q2 2020

Jul 27, 2020

BUY
$197.81 - $242.74 $17.3 Million - $21.3 Million
87,660 Added 85.04%
190,739 $45 Million
Q1 2020

May 15, 2020

SELL
$182.24 - $241.7 $17.9 Million - $23.8 Million
-98,405 Reduced 48.84%
103,079 $20.9 Million
Q4 2019

Feb 10, 2020

SELL
$189.21 - $243.2 $413,613 - $531,635
-2,186 Reduced 1.07%
201,484 $48.6 Million
Q3 2019

Oct 30, 2019

SELL
$174.11 - $208.62 $22.6 Million - $27.1 Million
-129,967 Reduced 38.95%
203,670 $39.4 Million
Q2 2019

Jul 23, 2019

SELL
$166.7 - $195.41 $1.04 Million - $1.21 Million
-6,209 Reduced 1.83%
333,637 $61.5 Million
Q1 2019

May 07, 2019

BUY
$180.87 - $203.88 $1.38 Million - $1.55 Million
7,627 Added 2.3%
339,846 $64.6 Million
Q4 2018

Feb 01, 2019

BUY
$178.4 - $208.25 $6.31 Million - $7.36 Million
35,360 Added 11.91%
332,219 $64.7 Million
Q3 2018

Nov 19, 2018

BUY
$185.29 - $208.89 $53.6 Million - $60.4 Million
289,086 Added 3719.1%
296,859 $61.5 Million
Q2 2018

Jul 26, 2018

SELL
$166.05 - $186.51 $33.2 Million - $37.3 Million
-200,000 Reduced 96.26%
7,773 $38.4 Million
Q2 2018

Jul 26, 2018

BUY
$166.05 - $186.51 $14.2 Million - $15.9 Million
85,443 Added 69.85%
207,773 $38.4 Million
Q1 2018

May 15, 2018

SELL
$169.43 - $198.0 $719,230 - $840,510
-4,245 Reduced 3.35%
122,330 $20.9 Million
Q4 2017

Feb 12, 2018

BUY
$168.79 - $188.59 $5.64 Million - $6.3 Million
33,410 Added 35.86%
126,575 $22 Million
Q3 2017

Nov 09, 2017

BUY
$167.29 - $191.0 $15.3 Million - $17.5 Million
91,455 Added 5348.25%
93,165 $17.4 Million
Q2 2017

Aug 11, 2017

BUY
N/A
1,710
1,710 $295,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Sawgrass Asset Management LLC Portfolio

Follow Sawgrass Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sawgrass Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sawgrass Asset Management LLC with notifications on news.